What is HALO?
HALO is a specialized Bioclass protein column solution developed and manufactured by Advanced Materials Technology. The company's offerings are critical for applications within the biopharma, environmental analysis, and small molecule solution sectors. The company's focus on high-performance chromatography solutions underscores its commitment to advancing scientific research and development through precise analytical tools.
How much funding has HALO raised?
HALO has raised a total of $350K across 1 funding round:
Debt
$350K
Debt (2020): $350K with participation from PPP
Key Investors in HALO
PPP
Public-Private Partnership
What's next for HALO?
With its large-scale, late-stage funding context, HALO is poised for significant expansion and market penetration. The recent strategic investment suggests a strong validation of the company's technology and market strategy. Future initiatives are likely to focus on scaling production, enhancing product development, and broadening its customer base within the biopharmaceutical and environmental testing industries. This strategic backing will enable HALO to further solidify its position as a key player in the advanced materials and analytical solutions market.
See full HALO company page
